{"id":"W4407316344","doi":"10.1371/journal.pgph.0004268","title":"Global availability of medications and health technologies for kidney care: A multinational study from the ISN-GKHA","year":2025,"lang":"en","type":"article","venue":"PLOS Global Public Health","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; University of Alberta; University of British Columbia","funders":"Daiichi Sankyo Europe; Medical Research Council; Chugai Pharmaceutical; Akebia Therapeutics; Astellas Pharma; University of Alberta; International Society of Nephrology; National Health and Medical Research Council; BioCryst; Fresenius Medical Care North America; AstraZeneca; Eli Lilly and Company; Heart and Stroke Foundation of Canada; Servier; Amgen","keywords":"Medicine; Business; Health care; Population; Cinacalcet; Global health; Developing country; Kidney disease; Family medicine; Environmental health; Economic growth; Public health; Nursing; Internal medicine; Parathyroid hormone; Secondary hyperparathyroidism; Economics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008114204,0.0001611037,0.0004731488,0.00004948864,0.0002932988,0.00003139414,0.0002492718,0.00008653551,0.00003430832],"category_scores_gemma":[0.004253402,0.0001166848,0.00007990693,0.0006958073,0.0002808828,0.00007772188,0.0001714538,0.0001138075,0.000002306266],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001245896,"about_ca_system_score_gemma":0.01223382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002746892,"about_ca_topic_score_gemma":0.0006259101,"domain_scores_codex":[0.9979774,0.0001378793,0.0005876891,0.0004413948,0.00041854,0.0004371453],"domain_scores_gemma":[0.9981111,0.0002662103,0.0002140504,0.0005923014,0.0004030302,0.0004132966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004339412,0.001899139,0.8472804,0.0007808133,0.0003317175,3.052679e-7,0.0005498578,2.469984e-7,0.000001184149,0.007684001,0.09464919,0.04677968],"study_design_scores_gemma":[0.004610736,0.0006426441,0.9409283,0.0002670613,0.0001367833,0.000001025363,0.01170318,0.0003353206,0.000005127459,0.00447577,0.03678645,0.0001076384],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2829765,0.01851933,0.0006028243,0.6836224,0.0002298462,0.005078389,0.007233576,0.0003552755,0.001381913],"genre_scores_gemma":[0.9843645,0.0001535724,0.0009062553,0.0137314,0.00004503266,0.0002651815,0.0005133151,0.00000525793,0.00001548376],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.701388,"threshold_uncertainty_score":0.9933659,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0410523624614061,"score_gpt":0.3668916039101251,"score_spread":0.325839241448719,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}